How long can you live after being cured of stage II nasopharyngeal carcinoma

Nasopharyngeal carcinoma may be related to EB and viral infection, and there may be no obvious symptoms in the early stage. As the disease progresses, symptoms such as cervical lymphadenopathy, nasal obstruction or nose bleeding will appear. After patients with early nasopharyngeal carcinoma receive precise radiotherapy, the 5-year survival rate can reach 70%-90%. Even patients with advanced nasopharyngeal carcinoma are more likely to survive for 5 years with effective treatment. Stage III nasopharyngeal carcinoma has reached the middle and late stages. It is not possible to generalize how long a patient can live, and a comprehensive evaluation is needed.

What are the oral targeted drugs for nasopharyngeal carcinoma?

Targeted drugs for nasopharyngeal carcinoma mainly include monoclonal antibodies and tyrosine kinase inhibitors. Monoclonal antibodies include cetuximab, panitumumab, bevacizumab, nimotuzumab, etc. Most of these monoclonal antibody targeted drugs require chemotherapy to achieve the best therapeutic effect. If used alone, the control rate of nasal cancer is generally low. Generally, one pill is taken a day. The other two are very expensive. These three drugs can be chosen. The efficiency is limited. It cannot be said that the domestic efficiency is low. It is recommended to make a comprehensive choice based on your economic situation. Targeted drugs for nasopharyngeal carcinoma mainly include monoclonal antibodies and tyrosine kinase inhibitors.

Are multiple small nodules in both lungs related to nasopharyngeal carcinoma?

Patients with nasopharyngeal carcinoma are accompanied by lung metastasis, multiple small nodules, late stage of the disease, severe condition, no surgical indications, and can only be treated conservatively. It is recommended that patients be hospitalized in the oncology department of a regular hospital as soon as possible, comprehensively evaluate their condition and constitution, and select appropriate chemotherapy drugs for systemic treatment as soon as possible, while cooperating with local radiotherapy of the nasopharynx. Common small nodules in both lungs are not necessarily absolutely related to nasopharyngeal carcinoma. These patients first need to clarify whether the nodules have changed. If there are no changes, it is not a big problem and regular check-ups are required. If the changes are obvious, you can go to the hospital for detailed examination, and a puncture biopsy can be performed if necessary. You need to see the severity of the nasopharyngeal carcinoma.